Nexthera Capital as of June 30, 2019
Portfolio Holdings for Nexthera Capital
Nexthera Capital holds 23 positions in its portfolio as reported in the June 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Intercept Pharmaceuticals In | 10.1 | $12M | 152k | 79.57 | |
| Insmed (INSM) | 10.0 | $12M | 471k | 25.60 | |
| Audentes Therapeutics | 9.3 | $11M | 294k | 37.86 | |
| Neurocrine Biosciences (NBIX) | 6.5 | $7.8M | 92k | 84.43 | |
| Sarepta Therapeutics (SRPT) | 6.4 | $7.6M | 50k | 151.96 | |
| Global Blood Therapeutics In | 6.2 | $7.5M | 142k | 52.60 | |
| Immunomedics | 6.0 | $7.3M | 524k | 13.87 | |
| Coherus Biosciences (CHRS) | 5.8 | $7.0M | 316k | 22.10 | |
| Ascendis Pharma A S (ASND) | 5.8 | $6.9M | 60k | 115.16 | |
| Pacira Pharmaceuticals (PCRX) | 5.4 | $6.5M | 149k | 43.49 | |
| Urogen Pharma (URGN) | 5.3 | $6.4M | 177k | 35.94 | |
| Uniqure Nv (QURE) | 3.9 | $4.7M | 60k | 78.15 | |
| Amarin Corporation (AMRN) | 3.7 | $4.5M | 230k | 19.39 | |
| Abbvie (ABBV) | 3.2 | $3.8M | 53k | 72.72 | |
| Biohaven Pharmaceutical Holding | 3.1 | $3.8M | 86k | 43.79 | |
| Mylan Nv | 1.6 | $2.0M | 103k | 19.04 | |
| Intra Cellular Therapies (ITCI) | 1.6 | $1.9M | 144k | 12.98 | |
| Regeneron Pharmaceuticals (REGN) | 1.5 | $1.8M | 5.7k | 312.99 | |
| Madrigal Pharmaceuticals (MDGL) | 1.4 | $1.6M | 15k | 104.78 | |
| Dermira | 1.1 | $1.3M | 138k | 9.56 | |
| Gilead Sciences (GILD) | 1.1 | $1.3M | 19k | 67.55 | |
| Anaptysbio Inc Common (ANAB) | 0.6 | $679k | 12k | 56.46 | |
| Allergan | 0.5 | $560k | 3.3k | 167.31 |
